BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu GT, Li Y, Wei HL, Lu H, Zhang H, Gao YG, Wang LZ. Toxicity of novel anti-hepatitis drug bicyclol: A preclinical study. World J Gastroenterol 2005; 11(5): 665-671 [PMID: 15655818 DOI: 10.3748/wjg.v11.i5.665]
URL: https://www.wjgnet.com/1007-9327/full/v11/i5/665.htm
Number Citing Articles
1
Ying Luo, Bo Zhang, Dun-Quan Xu, Yi Liu, Ming-Qing Dong, Peng-Tao Zhao, Zhi-Chao Li. Protective effect of bicyclol on lipopolysaccharide-induced acute lung injury in micePulmonary Pharmacology & Therapeutics 2011; 24(2): 240 doi: 10.1016/j.pupt.2010.12.005
2
Tianming Zhao, Lihong Mao, Zihan Yu, Yangyang Hui, Hongjuan Feng, Xiaoyu Wang, Lin Lin, Xiaofei Fan, Xin Chen, Bangmao Wang, Xiaocang Cao, Chao Sun. Therapeutic potential of bicyclol in liver diseases: Lessons from a synthetic drug based on herbal derivative in traditional Chinese medicineInternational Immunopharmacology 2021; 91: 107308 doi: 10.1016/j.intimp.2020.107308
3
Si-Yuan Pan, Hang Dong, Zhi-Ling Yu, Xin-Ye Zhao, Chun-Jing Xiang, Hui Wang, Wang-Fun Fong, Kam-Ming Ko. Bicyclol, a synthetic dibenzocyclooctadiene derivative, decreases hepatic lipids but increases serum triglyceride level in normal and hypercholesterolaemic miceJournal of Pharmacy and Pharmacology 2010; 59(12): 1657 doi: 10.1211/jpp.59.12.0007
4
M. V. Maevskaya, V. D. Lunkov, N. I. Geyvandova, L. K. Palgova, I. Yu. Pirogova, M. K. Prashnova, N. V. Marchenko, E. N. Zinovieva, T. A. Ilchishina, V. T. Ivashkin, P. V. Koroy. Bicyclol in the treatment of patients with chronic diffuse liver diseasesMeditsinskiy sovet = Medical Council 2020; (15): 78 doi: 10.21518/2079-701X-2020-15-78-89
5
Jie Cui, Zhi Li, Ling-bo Qian, Qin Gao, Jue Wang, Meng Xue, Xiao-e Lou, Iain C. Bruce, Qiang Xia, Hui-ping Wang. Reducing the oxidative stress mediates the cardioprotection of bicyclol against ischemia-reperfusion injury in ratsJournal of Zhejiang University SCIENCE B 2013; 14(6): 487 doi: 10.1631/jzus.B1200263
6
O. D. Ostroumova, E. V. Borisova, G. F. Piksina, E. Е. Pavleeva. Drug-induced liver injuries in practice of primary care physician (review of clinical recommendations)Medical alphabet 2020; (21): 58 doi: 10.33667/2078-5631-2020-21-58-68
7
Vladimir T. Ivashkin, Andrey Yu. Baranovsky, Karina L. Raikhelson, Lyudmila K. Palgova, Marina V. Maevskaya, Elina A. Kondrashina, Natalya V. Marchenko, Tatyana P. Nekrasova, Igor G. Nikitin. Drug-Induced Liver Injuries (Clinical Guidelines for Physicians)Russian Journal of Gastroenterology, Hepatology, Coloproctology 2019; 29(1): 101 doi: 10.22416/1382-4376-2019-29-1-101-131
8
Xiao‐min Yao, Hui Chen, Yan Li. Protective effect of bicyclol on liver injury induced by hepatic warm ischemia/reperfusion in ratsHepatology Research 2009; 39(8): 833 doi: 10.1111/j.1872-034X.2009.00504.x
9
Ming-Wei Wang, Xiaojiang Hao, Kaixian Chen. Biological screening of natural products and drug innovation in ChinaPhilosophical Transactions of the Royal Society B: Biological Sciences 2007; 362(1482): 1093 doi: 10.1098/rstb.2007.2036
10
Yanchao Liu, Mengqi Jia, An Gao, Xucong Huang, Xiaojing Li, Lingyi Guo, Zhenghua Wu, Yuan Yu, Guorong Fan, Kondareddy Cherukula. Attenuation of Liver Injury via Bicyclol–Bovine Serum Albumin Nanopreparation using a Green Synthetic ApproachJournal of Nanomaterials 2022; 2022: 1 doi: 10.1155/2022/7740768
11
V. T. Ivashkin, K. L. Raikhelson, L. K. Palgova, M. V. Maevskaya, O. A. Gerasimova, E. A. Kondrashina, N. V. Marchenko, A. Yu. Baranovsky. Drug-induced liver injury in cancer patientsOncohematology 2020; 15(3): 80 doi: 10.17650/1818-8346-2020-15-3-80-94
12
Jae Kuk Ryu, Sun Dong Yoo. Preparation and evaluation of bicyclol microemulsions for enhanced oral bioavailabilityDrug Development and Industrial Pharmacy 2012; 38(11): 1313 doi: 10.3109/03639045.2011.650643
13
Qian-qian Zhang, Qiang Li, Lin Dong, Wan-fang Li, Chao Li, Ai-ping Wang, Jin-feng Wei, Hong-tao Jin. Genotoxicity and Embryotoxicity Study of Bicyclol Methyl Ether, Main Impurity in BicyclolChinese Journal of Integrative Medicine 2019; 25(10): 743 doi: 10.1007/s11655-018-2553-x